Jagran Prakashan Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:51 am

Competitors of Jagran Prakashan Ltd

All Competitor Stocks of Jagran Prakashan Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:00 pm

Below is a detailed analysis of the quarterly data for Jagran Prakashan Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 460.00 Cr.. The value appears to be declining and may need further review. It has decreased from 481.00 Cr. (Mar 2025) to 460.00 Cr., marking a decrease of 21.00 Cr..
• For Expenses, as of Jun 2025, the value is 396.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 547.00 Cr. (Mar 2025) to 396.00 Cr., marking a decrease of 151.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from -66.00 Cr. (Mar 2025) to 64.00 Cr., marking an increase of 130.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears strong and on an upward trend. It has increased from -14.00% (Mar 2025) to 14.00%, marking an increase of 28.00%.
• For Other Income, as of Jun 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 52.00 Cr., marking an increase of 18.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from -65.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 155.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from -21.00% (Mar 2025) to 26.00%, marking an increase of 47.00%.
• For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from -51.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 118.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.09. The value appears strong and on an upward trend. It has increased from -0.73 (Mar 2025) to 3.09, marking an increase of 3.82.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:07 am

Growth

Last Updated: September 5, 2025, 8:00 am

Balance Sheet

Last Updated: November 9, 2025, 2:17 pm

Below is a detailed analysis of the balance sheet data for Jagran Prakashan Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 44.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,899.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,904.00 Cr. (Mar 2025) to 1,899.00 Cr., marking a decrease of 5.00 Cr..
• For Borrowings, as of Sep 2025, the value is 198.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 186.00 Cr. (Mar 2025) to 198.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 669.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 570.00 Cr. (Mar 2025) to 669.00 Cr., marking an increase of 99.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,809.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,702.00 Cr. (Mar 2025) to 2,809.00 Cr., marking an increase of 107.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 736.00 Cr.. The value appears to be declining and may need further review. It has decreased from 747.00 Cr. (Mar 2025) to 736.00 Cr., marking a decrease of 11.00 Cr..
• For CWIP, as of Sep 2025, the value is 17.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 5.00 Cr..
• For Investments, as of Sep 2025, the value is 1,122.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,068.00 Cr. (Mar 2025) to 1,122.00 Cr., marking an increase of 54.00 Cr..
• For Other Assets, as of Sep 2025, the value is 935.00 Cr.. The value appears strong and on an upward trend. It has increased from 874.00 Cr. (Mar 2025) to 935.00 Cr., marking an increase of 61.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,809.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,702.00 Cr. (Mar 2025) to 2,809.00 Cr., marking an increase of 107.00 Cr..

Notably, the Reserves (1,899.00 Cr.) exceed the Borrowings (198.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Jagran Prakashan Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.02. This value is within the healthy range. It has decreased from 8.44 (Mar 24) to 6.02, marking a decrease of 2.42.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.02. This value is within the healthy range. It has decreased from 8.44 (Mar 24) to 6.02, marking a decrease of 2.42.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.26. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 9.26, marking a decrease of 3.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 89.02. It has decreased from 95.71 (Mar 24) to 89.02, marking a decrease of 6.69.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 89.02. It has decreased from 95.71 (Mar 24) to 89.02, marking a decrease of 6.69.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 86.75. It has decreased from 88.85 (Mar 24) to 86.75, marking a decrease of 2.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 12.20. This value is within the healthy range. It has decreased from 16.60 (Mar 24) to 12.20, marking a decrease of 4.40.
• For PBIT / Share (Rs.), as of Mar 25, the value is 7.25. This value is within the healthy range. It has decreased from 11.49 (Mar 24) to 7.25, marking a decrease of 4.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 6.26. This value is within the healthy range. It has decreased from 10.22 (Mar 24) to 6.26, marking a decrease of 3.96.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.30. This value is within the healthy range. It has decreased from 7.56 (Mar 24) to 4.30, marking a decrease of 3.26.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.02. This value is within the healthy range. It has decreased from 8.44 (Mar 24) to 6.02, marking a decrease of 2.42.
• For PBDIT Margin (%), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 18.68 (Mar 24) to 14.06, marking a decrease of 4.62.
• For PBIT Margin (%), as of Mar 25, the value is 8.35. This value is below the healthy minimum of 10. It has decreased from 12.92 (Mar 24) to 8.35, marking a decrease of 4.57.
• For PBT Margin (%), as of Mar 25, the value is 7.22. This value is below the healthy minimum of 10. It has decreased from 11.50 (Mar 24) to 7.22, marking a decrease of 4.28.
• For Net Profit Margin (%), as of Mar 25, the value is 4.95. This value is below the healthy minimum of 5. It has decreased from 8.50 (Mar 24) to 4.95, marking a decrease of 3.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.93. This value is below the healthy minimum of 8. It has decreased from 9.50 (Mar 24) to 6.93, marking a decrease of 2.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.75. This value is below the healthy minimum of 15. It has decreased from 9.57 (Mar 24) to 6.75, marking a decrease of 2.82.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.10. This value is below the healthy minimum of 10. It has decreased from 10.70 (Mar 24) to 7.10, marking a decrease of 3.60.
• For Return On Assets (%), as of Mar 25, the value is 4.78. This value is below the healthy minimum of 5. It has decreased from 6.44 (Mar 24) to 4.78, marking a decrease of 1.66.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.67. It has increased from 0.66 (Mar 24) to 0.67, marking an increase of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
• For Quick Ratio (X), as of Mar 25, the value is 2.79. This value exceeds the healthy maximum of 2. It has increased from 2.18 (Mar 24) to 2.79, marking an increase of 0.61.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 34.39. This value exceeds the healthy maximum of 8. It has increased from 6.84 (Mar 24) to 34.39, marking an increase of 27.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 83.12. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 24) to 83.12, marking an increase of 83.12.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 45.58. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 45.58, marking an increase of 45.58.
• For Earning Retention Ratio (%), as of Mar 25, the value is 16.88. This value is below the healthy minimum of 40. It has increased from 0.00 (Mar 24) to 16.88, marking an increase of 16.88.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 54.42. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 54.42, marking an increase of 54.42.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 13.10 (Mar 24) to 12.38, marking a decrease of 0.72.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 6.96 (Mar 24) to 5.37, marking a decrease of 1.59.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,600.62. It has decreased from 2,358.39 (Mar 24) to 1,600.62, marking a decrease of 757.77.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.22 (Mar 24) to 0.84, marking a decrease of 0.38.
• For EV / EBITDA (X), as of Mar 25, the value is 6.03. This value is within the healthy range. It has decreased from 6.53 (Mar 24) to 6.03, marking a decrease of 0.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.79, marking a decrease of 0.37.
• For Retention Ratios (%), as of Mar 25, the value is 16.87. This value is below the healthy minimum of 30. It has increased from 0.00 (Mar 24) to 16.87, marking an increase of 16.87.
• For Price / BV (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.77, marking a decrease of 0.39.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.79, marking a decrease of 0.37.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness